XML 25 R12.htm IDEA: XBRL DOCUMENT v3.25.2
Earnings (Loss) per Share
 6 Months Ended
Aug. 02, 2025
Earnings Per Share [Abstract]  
Earnings (Loss) per Share Earnings (Loss) per Share
The computation of basic and diluted net earnings (loss) per common share attributable to common stockholders is (in thousands, except per share data):
 Three Months EndedSix Months Ended
 Aug 2, 2025Aug 3, 2024Aug 2, 2025Aug 3, 2024
Net earnings (loss) attributable to Guess?, Inc.$6,242 $(10,603)$(26,686)$2,419 
Less net earnings attributable to nonvested restricted stockholders193 160 405 478 
Net earnings (loss) attributable to common stockholders6,049 (10,763)(27,091)1,941 
Remove income related to the convertible senior notes1
— (8,215)— — 
Net earnings (loss) attributable to common stockholders used in diluted computations
$6,049 $(18,978)$(27,091)$1,941 
Weighted average common shares used in basic computations51,499 52,436 51,437 52,672 
Effect of dilutive securities:
Stock options and restricted stock units616 — — 1,446 
Convertible senior notes— 14,656 — — 
Weighted average common shares used in diluted computations52,115 67,092 51,437 54,118 
Net earnings (loss) per common share attributable to common stockholders:
Basic
$0.12 $(0.21)$(0.53)$0.04 
Diluted
$0.12 $(0.28)$(0.53)$0.04 
______________________________________________________________________
Notes:
1Expenses (income) related to the convertible senior notes include interest expense, loss on extinguishment of debt and (gain) loss on fair value remeasurement for embedded derivative, as applicable, net of associated income tax effect.
Certain potentially dilutive common stock, including certain equity awards granted that were outstanding as well as shares issuable under convertible senior notes, are not included in the computation of diluted weighted average common shares and potential common shares outstanding if their effect would have been
antidilutive. Antidilutive shares excluded from the computation of diluted weighted average common shares and potential common shares outstanding are:
 Three Months EndedSix Months Ended
 Aug 2, 2025Aug 3, 2024Aug 2, 2025Aug 3, 2024
Stock options and restricted stock units1
2,311,183 1,678,508 3,143,877 227,548 
Convertible senior notes (as converted)16,093,559 1,095,935 16,016,212 15,792,171 
Total18,404,742 2,774,443 19,160,089 16,019,719 
______________________________________________________________________
Notes:
1During the six months ended August 2, 2025, 541,873 potentially dilutive shares were excluded given the Company’s net loss and 2,602,004 potentially dilutive shares were excluded because the assumed proceeds resulted in these awards being antidilutive. During the three months ended August 3, 2024, 1,398,312 potentially dilutive shares were excluded given the Company’s net loss and 280,196 potentially dilutive shares were excluded because the assumed proceeds resulted in these awards being antidilutive.
Additionally, for the three and six months ended August 2, 2025, the Company excluded 356,124 nonvested stock units which were subject to the achievement of performance-based or market-based vesting conditions from the computation of diluted weighted average common shares and potential common shares outstanding because these conditions were not achieved as of August 2, 2025. For the three and six months ended August 3, 2024, the Company excluded 300,000 nonvested stock units which were subject to the achievement of market-based vesting conditions from the computation of diluted weighted average common shares and potential common shares outstanding because these conditions were not achieved as of August 3, 2024.
There were no warrants related to the 2.00% convertible senior notes due April 2024 (the “2024 Notes”) outstanding as of August 2, 2025. Warrants related to the 2024 Notes to purchase approximately 1.3 million shares of the Company’s common shares at an adjusted strike price of $41.08 per share were outstanding as of August 3, 2024. Warrants related to the 3.75% convertible senior notes due April 2028 (the “2028 Notes”, and together with the 2024 Notes, the “Notes”) to purchase approximately 16.1 million and 15.8 million shares of the Company’s common shares at adjusted strike prices of $36.89 and $37.76 per share were outstanding as of August 2, 2025 and August 3, 2024, respectively. During the three and six months ended August 2, 2025 and August 3, 2024, these warrants were excluded from the computation of diluted net earnings (loss) per share since the warrants’ strike prices were greater than the average market price of the Company’s common stock. See Note 11 - Convertible Senior Notes and Related Transactions for more information regarding the Notes and related hedge transactions.